Silicon Nanoparticle Delivery Coating for Controlled OSA Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing delivery systems for pharmaceutical and cosmetic active ingredients face challenges in achieving controlled and slow-release mechanisms, stability, and biocompatibility, particularly for large or labile compounds, with silicon-based carriers often leading to uncontrolled OSA polymerization and safety issues.
Innovation Solution
Treating silicon nanoparticles with a combination of lipids and amino acids to control the hydrolysis rate, stabilizing the release of orthosilicic acid (OSA) and active agents, ensuring controlled release and biocompatibility.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of moving object
If silicon-based carriers are used for controlled release, then delivery control is improved, but OSA polymerization occurs causing safety issues
Solution Approach 1:
Amino acids serve as intermediary substances that bind to orthosilicic acid, preventing its polymerization into harmful forms. The amino acids act as mediators between the silicon carrier and the biological system, controlling the release pathway to ensure safety while maintaining controlled release functionality.
Solution Approach 2:
The invention changes the chemical parameters of the release environment by introducing amino acids that alter the polymerization pathway of OSA. This parameter change transforms the harmful polymerization process into a controlled release mechanism that produces beneficial amino acid-OSA complexes.
2Speed
If topical delivery systems are used, then penetration enhancement is improved, but biocompatibility deteriorates due to irritation and inflammation
Solution Approach 1:
The invention uses composite materials combining silicon nanoparticles with amino acids and lipid coatings. This composite structure provides both the penetration enhancement capabilities needed for effective topical delivery and the biocompatibility required to avoid irritation and inflammation, resolving the contradiction between speed and safety.
3Ease of operation
If conventional delivery vehicles are used, then immediate contact is improved, but residency time deteriorates due to short停留 time on skin
Solution Approach 1:
The delivery system uses a nested structure where active ingredients are encapsulated within amino acid complexes, which are in turn associated with silicon nanoparticle carriers. This nested arrangement allows immediate contact upon application while the layered structure provides sustained release over extended residency time on the skin.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method enables stable, controlled release of active agents, preventing OSA polymerization and enhancing biocompatibility, suitable for a wide range of active ingredients, including hydrophobic and labile compounds.
Implementation Method 1
controlling the rate of hydrolysis of the silicon nanoparticle, such that the silicon nanoparticle hydrolyses to the bioavailable OSA degradation product
Implementation Method 2
stabilizing the release of orthosilicic acid (OSA) and active agents, preventing OSA polymerization
Implementation Method 3
treating the surface of the silicon nanoparticle with at least one lipid and at least one amino acid
Data Source
AI summary
A method for promoting the controlled binding and release of a bioactive or pharmaceutical agent from a composition comprising silicon nanoparticles, wherein the silicon nanoparticles comprise at least 50% by weight silicon, the method comprising treating the surface of the silicon nanoparticles with at least one lipid, and treating the surface of the silicon nanoparticles with at least one amino acid, wherein the ratio of lipid to silicon is from 1:1 to 15:1. Also related compositions and methods.